Stefan Scherer, M.D., Ph.D.

Chief Executive Officer & President 3Tbiosciences

Dr. Scherer is a physician-scientist with more than 20 years of experience in biopharmaceutical research and development. Before joining 3T, he was president and CEO of ElyxBio, Inc., worked as global head of experimental medicine at Glaxo SmithKline, served as chief medical officer at Cellectis, an allogenic CAR-T company, and was head of early development, strategy, and innovation for U.S. Oncology at Novartis. Before Novartis, Dr. Scherer served in key roles at F. Hoffman-La Roche and Genentech, leading the global biomarker and translational medicine department.